$2.58 EPS Expected for HCA Healthcare Inc (HCA) This Quarter

Brokerages predict that HCA Healthcare Inc (NYSE:HCA) will announce earnings per share of $2.58 for the current quarter, according to Zacks Investment Research. Ten analysts have issued estimates for HCA Healthcare’s earnings, with the lowest EPS estimate coming in at $2.46 and the highest estimate coming in at $2.68. HCA Healthcare posted earnings of $2.12 per share in the same quarter last year, which indicates a positive year over year growth rate of 21.7%. The firm is expected to issue its next earnings report on Tuesday, January 29th.

On average, analysts expect that HCA Healthcare will report full-year earnings of $9.35 per share for the current year, with EPS estimates ranging from $9.23 to $9.45. For the next year, analysts forecast that the company will post earnings of $10.12 per share, with EPS estimates ranging from $9.39 to $10.50. Zacks’ earnings per share averages are a mean average based on a survey of research analysts that follow HCA Healthcare.

HCA Healthcare (NYSE:HCA) last released its earnings results on Tuesday, October 30th. The company reported $2.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.93 by $0.23. The company had revenue of $11.45 billion for the quarter, compared to analyst estimates of $11.29 billion. HCA Healthcare had a negative return on equity of 73.71% and a net margin of 6.82%. HCA Healthcare’s quarterly revenue was up 7.1% on a year-over-year basis. During the same period in the prior year, the firm posted $1.13 EPS.

Several analysts have recently issued reports on HCA shares. Credit Suisse Group increased their target price on HCA Healthcare from $156.00 to $165.00 and gave the stock an “outperform” rating in a report on Thursday, November 1st. Jefferies Financial Group raised their price objective on HCA Healthcare to $155.00 and gave the company a “buy” rating in a research note on Friday, September 21st. SunTrust Banks raised their price objective on HCA Healthcare to $150.00 and gave the company a “positive” rating in a research note on Tuesday, September 4th. Morgan Stanley raised their price objective on HCA Healthcare from $115.00 to $124.00 and gave the company an “underweight” rating in a research note on Wednesday, September 5th. Finally, Cantor Fitzgerald reaffirmed a “buy” rating and issued a $115.00 price objective on shares of HCA Healthcare in a research note on Friday, July 20th. Two analysts have rated the stock with a sell rating, four have assigned a hold rating and sixteen have assigned a buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus target price of $141.53.

In other news, SVP Jane D. Englebright sold 6,543 shares of HCA Healthcare stock in a transaction dated Wednesday, August 15th. The stock was sold at an average price of $129.86, for a total transaction of $849,673.98. Following the sale, the senior vice president now directly owns 7,443 shares of the company’s stock, valued at $966,547.98. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Michael S. Cuffe sold 5,196 shares of HCA Healthcare stock in a transaction dated Friday, November 2nd. The shares were sold at an average price of $136.52, for a total value of $709,357.92. The disclosure for this sale can be found here. Insiders sold 22,486 shares of company stock worth $3,079,086 over the last ninety days. 2.80% of the stock is currently owned by insiders.

Hedge funds have recently made changes to their positions in the company. Smithfield Trust Co. boosted its stake in shares of HCA Healthcare by 541.9% during the second quarter. Smithfield Trust Co. now owns 995 shares of the company’s stock valued at $102,000 after purchasing an additional 840 shares in the last quarter. Signet Financial Management LLC bought a new position in shares of HCA Healthcare during the second quarter worth about $137,000. Peak Asset Management LLC bought a new position in shares of HCA Healthcare during the third quarter worth about $212,000. Private Advisor Group LLC bought a new position in shares of HCA Healthcare during the third quarter worth about $212,000. Finally, Adviser Investments LLC bought a new position in shares of HCA Healthcare during the second quarter worth about $159,000. 70.84% of the stock is currently owned by hedge funds and other institutional investors.

HCA opened at $143.95 on Friday. The firm has a market cap of $48.75 billion, a PE ratio of 21.84, a P/E/G ratio of 1.24 and a beta of 0.48. HCA Healthcare has a 52-week low of $74.26 and a 52-week high of $144.18.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 28th. Investors of record on Monday, December 3rd will be paid a $0.35 dividend. This represents a $1.40 annualized dividend and a yield of 0.97%. The ex-dividend date of this dividend is Friday, November 30th. HCA Healthcare’s dividend payout ratio (DPR) is presently 21.24%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Further Reading: How does inflation affect different investments?

Get a free copy of the Zacks research report on HCA Healthcare (HCA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply